Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Bauer

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Investigative Ophthalmology & Visual Science|January 17, 2012
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injurySusanna S Park, Sergio Caballero, Gerhard Bauer, et al.
Epilepsy Research|July 2, 2013
Midbrain-hindbrain malformations in patients with malformations of cortical development and epilepsy: a series of 220 patientsGiorgi Kuchukhidze, Florian Koppelstaetter, Iris Unterberger, et al.
Ophthalmology Science|February 16, 2026
Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and FeasibilitySusanna S Park, Jennifer McCormack, Dagmar Salazar, et al.
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Transfusion|November 2, 2018
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditionsFernando A Fierro, Nataly Magner, Julie Beegle, et al.
Molecular Neurobiology|December 14, 2011
Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseScott D Olson, Kari Pollock, Amal Kambal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectorsGerhard Bauer, Mo A Dao, Scott S Case, et al.
Frontiers in Immunology|June 6, 2018
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4<sup>+</sup> T LymphocytesMarkus D Lacher, Gerhard Bauer, Brian Fury, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 9, 2023
Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatumSandra M Holley, Jack C Reidling, Carlos Cepeda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 21, 2020
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trialGerson D Hernandez, Christine M Solinsky, Wendy J Mack, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Investigative Ophthalmology & Visual Science|January 17, 2012
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injurySusanna S Park, Sergio Caballero, Gerhard Bauer, et al.
Epilepsy Research|July 2, 2013
Midbrain-hindbrain malformations in patients with malformations of cortical development and epilepsy: a series of 220 patientsGiorgi Kuchukhidze, Florian Koppelstaetter, Iris Unterberger, et al.
Ophthalmology Science|February 16, 2026
Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and FeasibilitySusanna S Park, Jennifer McCormack, Dagmar Salazar, et al.
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Transfusion|November 2, 2018
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditionsFernando A Fierro, Nataly Magner, Julie Beegle, et al.
Molecular Neurobiology|December 14, 2011
Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseScott D Olson, Kari Pollock, Amal Kambal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectorsGerhard Bauer, Mo A Dao, Scott S Case, et al.
Frontiers in Immunology|June 6, 2018
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4<sup>+</sup> T LymphocytesMarkus D Lacher, Gerhard Bauer, Brian Fury, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 9, 2023
Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatumSandra M Holley, Jack C Reidling, Carlos Cepeda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 21, 2020
Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trialGerson D Hernandez, Christine M Solinsky, Wendy J Mack, et al.
Pageof 12